Literature DB >> 1694924

Differential analysis of the frequency-dependent effects of class 1 antiarrhythmic drugs according to periodical ligand binding: implications for antiarrhythmic and proarrhythmic efficacy.

J Weirich1, H Antoni.   

Abstract

The frequency-dependent block of cardiac sodium channels by class 1 antiarrhythmic drugs can be described by a periodical ligand binding process between drug molecules and channel binding sites. This predicts a linear relation between onset-rate constant of frequency-dependent block and diastolic interval as well as saturation of block with high stimulation rates. From both relationships, the binding kinetics (time constant, tau on) and saturation level of block (bdinf) can be estimated. This is exemplified for the frequency-dependent block (reduction of the maximal upstroke velocity of action potentials) induced by prajmaline (10(-6) M). In the same way, the frequency-dependent effects of 11 other class 1 drugs reported in the literature were analyzed and compared with each other. When the drugs are ranked with respect to their binding kinetics (tau on), there is a close relationship to the subclasses (1a, 1b, 1c), with 1b drugs exhibiting the fastest and 1c drugs the slowest kinetics. However, differences also exist in the saturation behavior of frequency-dependent block even within the same subclasses (1a and 1c). Thus, the class 1 drugs can also be subdivided in three other groups exhibiting clearly separated bands of block-frequency relations, with half-maximal saturation occurring at different stimulation rates. Our findings may have differential implications for the antiarrhythmic and proarrhythmic efficacy of class 1 drugs.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1694924     DOI: 10.1097/00005344-199006000-00019

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  11 in total

Review 1.  Subclassification of class I antiarrhythmic drugs: enhanced relevance after CAST.

Authors:  T J Campbell
Journal:  Cardiovasc Drugs Ther       Date:  1992-10       Impact factor: 3.727

2.  Frequency-dependent action of antiarrhythmic drugs: the useful concept of periodical ligand binding.

Authors:  J Weirich
Journal:  Basic Res Cardiol       Date:  1992 May-Jun       Impact factor: 17.165

3.  Rate-dependent activation failure in isolated cardiac cells and tissue due to Na+ channel block.

Authors:  Anthony Varghese; Anthony J Spindler; David Paterson; Denis Noble
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-09-04       Impact factor: 4.733

4.  Effect of ajmaline on sustained ventricular tachycardia induced by programmed electrical stimulation in conscious dogs after myocardial infarction.

Authors:  H Todt; G Krumpl; N Zojer; K Krejcy; G Raberger
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-09       Impact factor: 3.000

5.  Kinetics of rate-dependent slowing of intraventricular conduction by the class Ib antiarrhythmic agent tocainide in vivo.

Authors:  H Todt; N Zojer; G Raberger
Journal:  Br J Pharmacol       Date:  1993-09       Impact factor: 8.739

6.  Electrocardiographic interactions between pinacidil, a potassium channel opener and class I antiarrhythmic agents in guinea-pig isolated perfused heart.

Authors:  Q Yang; R Padrini; S Bova; D Piovan; G Magnolfi
Journal:  Br J Pharmacol       Date:  1995-04       Impact factor: 8.739

Review 7.  Propafenone. A reappraisal of its pharmacology, pharmacokinetics and therapeutic use in cardiac arrhythmias.

Authors:  H M Bryson; K J Palmer; H D Langtry; A Fitton
Journal:  Drugs       Date:  1993-01       Impact factor: 9.546

8.  Enantioselectivity of asocainol studied at different conditions: a novel approach to check the feasibility of molecular models of antiarrhythmic drug action.

Authors:  J Gödicke; S Herzig; A Mescheder; K Mohr; F Steinke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-09       Impact factor: 3.000

9.  [Improving left ventricular contractility by stimulation during the absolute refractory period--cardiac contractility modulation (CCM)].

Authors:  M Seifert; J Hoffmann; J Meyhöfer; C Butter
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2008-12

Review 10.  Optimal treatment after acute myocardial infarction in the elderly.

Authors:  J Herlitz; M Hartford; M Dellborg; B W Karlson
Journal:  Drugs Aging       Date:  1995-03       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.